Anavex Life Sciences | 8-K: Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update
Anavex Life Sciences | DEF 14A: Definitive information statements
Anavex Life Sciences | DEFA14A: Others
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | DEFA14A: Others
Anavex Life Sciences | DEF 14A: Definitive proxy statements
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | DEFA14A: Others
Anavex Life Sciences | DEF 14A: Definitive proxy statements
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
No Data